Challenger Limited (CGF)

Index:

ASX 100

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $5.25
  • Currency: Australian Dollars
  • Shares Issued: 611.60m
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 1,032.49 669.34 60.40¢ 13.3 2.6 +5% 28.75¢ 0.0%
30-Jun-26 1,070.01 727.66 62.78¢ 12.8 3.2 +4% 29.66¢ 0.0%
30-Jun-27 1,129.74 773.91 66.37¢ 12.1 2.1 +6% 31.48¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-25 $1.69 4.76
30-Jun-26 $1.75 4.60
30-Jun-27 $1.85 4.35

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2026 1,070 1,066 n/a 1,064 1,109 1,133
30-Jun-2027 1,130 1,122 n/a 1,126 1,169 n/a
 
Earnings
30-Jun-2026 62.78¢ 63.09¢ n/a 61.98¢ 65.71¢ 67.18¢
30-Jun-2027 66.37¢ 66.03¢ n/a 65.78¢ 68.85¢ n/a
 
Dividend
30-Jun-2026 29.66¢ 29.58¢ n/a 29.58¢ 30.39¢ 30.39¢
30-Jun-2027 31.48¢ 31.45¢ n/a 31.75¢ 31.82¢ n/a
 
Recommendations
Strong Buy 4 0 4 4 3 3
Buy 6 0 7 8 4 3
Neutral 1 0 1 1 4 4
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 1 1
No. of Brokers 11 0 12 13 12 11
 
Average Rec 8.18 n/a 8.12 8.08 6.67 6.59

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

CGF Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $5.25
Shares Issued 611.60m

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 1
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page